Providing regenerative medicine solutions
Medical advances have led to a welcome increase in life expectancy. However, this has led to a rise in age-related diseases and healthcare costs. Trauma, injury, disease, or simply advancing years all result in tissue deterioration for which there are limited answers.
Renovos, a regenerative medicine company, offers a complementary range of products and services to address the needs of researchers and clinicians, developing solutions for tissue healing that is quicker, safer and more cost-effective.
“Renovos offers a step change in bone repair approaches with exciting new delivery vehicles, cells and assay protocols for bio-industry.”
Professor Richard Oreffo, Director of the Centre for Human Development, Stem Cells and Regeneration, University of Southampton, UK
The need for new approaches
There are nine million osteoporotic fractures worldwide each year and one in two women and one in five men aged over 50 experience them in UK. Fractures cost the NHS over £2 billion each year (US $20 billion, EU €32 billion) and yet many do not heal effectively using current approaches, with up to 10% of fractured bones failing to heal properly.
Transforming Patient Lives
Regenerative medicine – the use of new stem cell and material technologies – holds the promise of improving the healing process and therefore relieve pain and return patients to normal life sooner. Renovos aims to help develop and augment treatment plans to repair and replace diseased or damaged tissues to transform lives. Renovos is addressing the orthopaedic regenerative medicine market by offering unique skeletal cell populations, regenerative assays, and proprietary regenerative medicine technologies based on nanoclays.
Our products and technologies have been refined and developed over years of academic research and innovation.
Now, these regenerative medicine products and technologies are ready to be used by customers and partners.
Renovos welcomes enquiries from potential partners that might wish to utilise our technologies in their own development programmes or with an interest in partnering in one of Renovos’ in-house development programmes.